Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

Clinical trial NCT05775042 · RECRUITING

Trial details

NCT number: NCT05775042
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2023-05-08
Primary completion: 2027-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.